contact us  |  privacy policy

Sunday, July 5, 2009
  • Font size
  • Bookmark
  • Save

Strattera - Drug Description

atomoxetine HCl

Saturday, Oct. 20, 2007; 7:17 AM

DESCRIPTION

STRATTERA (atomoxetine HCl) is a selective norepinephrine reuptake inhibitor. Atomoxetine HCl is the R(-) isomer as determined by x-ray diffraction. The chemical designation is (-)-N-Methyl-3-phenyl-3-( o-tolyloxy)-propylamine hydrochloride. The molecular formula is C17H21NO° HCl, which corresponds to a molecular weight of 291.82.

Atomoxetine HCl is a white to practically white solid, which has a solubility of 27.8 mg/ mL in water. STRATTERA capsules are intended for oral administration only. Each capsule contains atomoxetine HCl equivalent to 10, 18, 25, 40, or 60 mg of atomoxetine. The capsules also contain pregelatinized starch and dimethicone. The capsule shells contain gelatin, sodium lauryl sulfate, and other inactive ingredients. The capsule shells also contain one or more of the following: FD& C Blue No. 2, synthetic yellow iron oxide, titanium dioxide. The capsules are imprinted with edible black ink.

  • Font size
  • Bookmark
  • Was this helpful? Yes
  • Save
TheHealthCentralNetwork  
Acid Reflux Connection Bipolar Connect My Diabetes Central High Blood Pressure Connection My Osteoarthritis Central
Allergy Network My Breast Cancer Network My Diet Exercise Incontinence Network My RA Central
Our Alzheimer's Cholesterol Network Erectile Dysfunction Connection My Migraine Connection Schizophrenia Connection
Anxiety Connection Chronic Pain Connection Herpes Connection Osteoporosis Connection Skin Cancer Connection
Asthma Central My Depression Connection My Heart Central Prostate Commons My Sleep Central